Katie Weimer, former Vice President of Regenerative Medication 3D Programs’ has launched GenesisTissue Inc., a biotechnology analysis startup.
Based in 2024, the startup has emerged from stealth mode, specializing in surgical planning, customized design, and the manufacturing of 3D bioprinted regenerative tissue implants for people. Whereas restricted particulars can be found, Weimer will function CEO and Co-Founding father of GenesisTissue, main a staff centered on growing biomimetic supplies designed to duplicate pure human tissue, prioritizing regeneration over restore.
Asserting the launch on LinkedIn, Weimer acknowledged, “I’m grateful for the experiences and development throughout my time at 3D Programs Company. Trying forward, I’m excited to collaborate, innovate, and form the way forward for healthcare with GenesisTissue. Keep tuned!”
The announcement has drawn trade consideration, with Rajeev Kulkarni, CSO of Axtra3D and former VP of Technique & Company Growth at 3D Programs, commenting on LinkedIN, “Looks like a super time for the AM trade to embrace tissue-like options designed particularly for therapeutic and restoration and maintain the innovative transferring.”
Weimer’s contributions to medical 3D printing
Weimer’s started her profession at Medical Modeling in 2007. After 3D Programs acquired the corporate, she transitioned into management roles, serving as Director of Product Growth, later advancing to VP of Medical Gadgets, and finally VP of Regenerative Medication.
Throughout her tenure, 3D Programs noticed the launch of the Regenerative Tissue Program (RTP) in 2023, which focuses on growing bioprinted patient-specific comfortable tissue. She described the initiative as a big step ahead in offering customized options for breast reconstruction.
By leveraging 3D modeling, bioprinting, and Digital Surgical Planning (VSP), this system goals to create bio-integrative scaffolds tailor-made to particular person sufferers. Weimer additionally noticed potential for increasing this work into purposes comparable to lumpectomies, breast augmentation, and facial implants, highlighting the broader affect of regenerative bioprinting in medication.
One of many groundbreaking instances she labored on was the profitable separation of conjoined twins, Jadon and Anias McDonald in 2016. Weimer and her staff collaborated carefully with surgeons, using medical imaging to create detailed 3D printed fashions of the twins’ shared cranial construction.
These fashions have been instrumental in pre-surgical planning, permitting the medical staff to visualise and strategize the complicated process. Weimer’s direct involvement prolonged to being current within the working room throughout the 27-hour surgical procedure, guaranteeing the correct utility of the 3D printed guides and fashions, which have been vital to the operation’s success.
Furthermore, she additionally contributed to SME’s 2018 report on the increasing position of medical 3D printing. On the time, point-of-care manufacturing was gaining momentum, permitting for quicker, extra customized options in surgical planning and prosthetics.
With that in thoughts, Weimer highlighted the trade’s reliance on industrial prototyping supplies and advocated for biomimetic alternate options that higher replicated human anatomy. She predicted a shift towards extra superior supplies, anticipating the evolution of 3D printing to additional improve affected person care and solidify its position in medical purposes.
With GenesisTissue, Weimer is getting into a brand new part of her profession, bringing her experience in bioprinting and regenerative medication right into a devoted enterprise. Additional particulars on the corporate’s improvement and partnerships are anticipated as GenesisTissue strikes ahead.
What 3D printing traits must you be careful for in 2025?
How is the way forward for 3D printing shaping up?
To remain updated with the newest 3D printing information, don’t overlook to subscribe to the 3D Printing Business publication or observe us on Twitter, or like our web page on Fb.
When you’re right here, why not subscribe to our Youtube channel? That includes dialogue, debriefs, video shorts, and webinar replays.
Featured picture exhibits Katie Weimer, CEO and Co-Founding father of GenesisTissue. Picture through Katie Weimer/LinkedIN.
